Spray drying is a key enabling technology within our small molecule manufacturing platform, supporting the conversion of solutions or suspensions into solid materials with controlled particle size, morphology, and solid state properties. It is applied both as an isolation step and as a tool for material property optimization, particularly where conventional crystallization approaches are not suitable or sufficiently robust.
Our manufacturing facilities feature large-scale spray drying systems that support flexible and reliable GMP production across different volumes. For early development, a laboratory spray dryer enables feasibility testing, process optimization, and smooth preparation for industrial production. Using process modeling technologies, we guide equipment selection, define optimal operating conditions, and ensure predictable scale up.
This integrated approach delivers efficient development, reliable scale translation, and consistent product quality. For our customers, spray drying offers a robust and scalable solution that supports demanding development timelines and long-term commercial supply.
What turns a technology into a strategic platform for pharmaceutical development?
FIS recognized the potential of spray drying early on. Today, that vision has evolved into an integrated and scalable approach, supporting pharmaceutical development from R&D to commercial production.
In this video of our series, Graziano Fabbrini and Stefano Berto share the expertise, approach and value behind spray drying at FIS.